Lipid Disorder News and Research

RSS
Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Scientists discover link between sugar metabolism and peroxisomal biogenesis disorders

Scientists discover link between sugar metabolism and peroxisomal biogenesis disorders

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

SCIEX and Metabolon® Launch the Lipidyzer™ Platform for Complete Lipid Analysis, from Sample to Biology

SCIEX and Metabolon® Launch the Lipidyzer™ Platform for Complete Lipid Analysis, from Sample to Biology

Genetic variation linked to increased levels of triglycerides associated with heart disorders

Genetic variation linked to increased levels of triglycerides associated with heart disorders

Omthera to be acquired by AstraZeneca

Omthera to be acquired by AstraZeneca

Karolinska Institutet professor receives Fernström Foundation Nordic Prize for obesity research

Karolinska Institutet professor receives Fernström Foundation Nordic Prize for obesity research

First signs of atherosclerotic heart disease may appear in early childhood

First signs of atherosclerotic heart disease may appear in early childhood

Scientists reveal link between lipid cell dysfunction and metabolic diseases

Scientists reveal link between lipid cell dysfunction and metabolic diseases

Efficacy of Abbott cholesterol drug in question

Efficacy of Abbott cholesterol drug in question

Aegerion third quarter net loss increases to $6.2 million

Aegerion third quarter net loss increases to $6.2 million

Omthera reaches agreement with FDA on SPA for Epanova Phase III trial in patients with very high triglycerides

Omthera reaches agreement with FDA on SPA for Epanova Phase III trial in patients with very high triglycerides

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Aegerion underwriters exercise over-allotment option

Aegerion underwriters exercise over-allotment option

Aegerion prices initial public offering of common stock

Aegerion prices initial public offering of common stock

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Abbott and AstraZeneca to co-promote Trilipix (fenofibric acid)

Abbott and AstraZeneca to co-promote Trilipix (fenofibric acid)